Nanosized Bilosomes as a Potential Platform for Improved Therapeutic Efficacy of Capecitabine Against Colon Cancer in Rats: Formulation, Evaluation, and Optimization.
- DOI
- 10.3390/ph19101531
- Published
- 2026 Sep 27
- Container
- Pharmaceuticals (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ph19101531,
title = {Nanosized Bilosomes as a Potential Platform for Improved Therapeutic Efficacy of Capecitabine Against Colon Cancer in Rats: Formulation, Evaluation, and Optimization.},
author = {Mostafa ME and Ramadan AEH and El-Shenawy AA and Kamal I and Hamed LB and Saad AS and Salama A and Mahrous M and Atwa GMK},
year = {2026},
journal = {Pharmaceuticals (Basel, Switzerland)},
doi = {10.3390/ph19101531},
url = {https://doi.org/10.3390/ph19101531}
}RIS
TY - JOUR TI - Nanosized Bilosomes as a Potential Platform for Improved Therapeutic Efficacy of Capecitabine Against Colon Cancer in Rats: Formulation, Evaluation, and Optimization. AU - Mostafa ME AU - Ramadan AEH AU - El-Shenawy AA AU - Kamal I AU - Hamed LB AU - Saad AS AU - Salama A AU - Mahrous M AU - Atwa GMK PY - 2026 JO - Pharmaceuticals (Basel, Switzerland) DO - 10.3390/ph19101531 UR - https://doi.org/10.3390/ph19101531 ER -
APA
ME, M., AEH, R., AA, E., I, K., LB, H., AS, S., A, S., M, M., & GMK, A. (2026). Nanosized Bilosomes as a Potential Platform for Improved Therapeutic Efficacy of Capecitabine Against Colon Cancer in Rats: Formulation, Evaluation, and Optimization.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19101531
Source records
- pubmed · retrieved 2026-11-10T07:07:06.571Z